JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGilliard, K. L.
Right arrow Articles by Takemori, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGilliard, K. L.
Right arrow Articles by Takemori, A. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MORPHINE
*NALOXONE

Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment

KL McGilliard and AE Takemori

Mice were pretreated either acutely or chronically with morphine to test the effect of such pretreatments on the antagonism by naloxone of morphine-induced respiratory depression and analgesia and to compare the development of tolerance to the two effects. A s.c. injection of 20 mg/kg of morphine 6 hr before testing produced a shift of the apparent pA2 of morphine-naloxone for analgesia from 7.05 to 7.33, while the same pretreatment did not change the apparent pA2 for respiratory depression. However, s.c. implantation of a morphine pellet for 72 hr produced a shift in the apparent pA2 of morphine-naloxone for respiratory depression from 7.35 to 7.63, which represents less than a 2-fold increase in naloxone potency. The same pretreatment produced a further shift of the apparent pA2 for analgesia to 7.58, representing a greater than 3-fold increase in naloxone potency. After morphine pellet implantation mice showed a much greater degree of tolerance to morphine- induced analgesia than to respiratory depression. These results provide further evidence that narcotic-induced respiratory depression and analgesia are mediated by different receptor interactions.

Volume 207, Issue 3, pp. 884-891, 12/01/1978
Copyright © 1978 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. Riba, Y. Ben, A. P. Smith, S. Furst, and N. M. Lee
Morphine Tolerance in Spinal Cord Is Due to Interaction between {micro}- and delta -Receptors
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. A. CZAPLA, D. GOZAL, O. A. ALEA, R. C. BECKERMAN, and J. E. ZADINA
Differential Cardiorespiratory Effects of Endomorphin 1, Endomorphin 2, DAMGO, and Morphine
Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 994 - 999.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
M. R. Brandt and C. P. France
Chronic l-alpha -Acetylmethadol (LAAM) in Rhesus Monkeys: Tolerance and Cross-Tolerance to the Antinociceptive, Ventilatory, and Rate-Decreasing Effects of Opioids
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 168 - 178.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. A. Paronis and J. H. Woods
Ventilation in Morphine-Maintained Rhesus Monkeys. II: Tolerance to the Antinociceptive But Not the Ventilatory Effects of Morphine,
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 355 - 362.
[Abstract] [Full Text]


Home page
ScienceHome page
D. Lange, S. Roerig, J. Fujimoto, and R. Wang
Absence of cross-tolerance to heroin in morphine-tolerant mice
Science, April 4, 1980; 208(4439): 72 - 74.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics.